32017R0776R(02)

EUR-Lex

Access to European Union law

This document is an excerpt from the EUR-Lex website

EUROPA
EUR-Lex home
EUR-Lex - 32017R0776R(02) - EN

Help

Search tips

Need more search options? Use the Advanced search

Document 32017R0776R(02)

Help

Rectificatie van Verordening (EU) 2017/776 van de Commissie van 4 mei 2017 tot wijziging van Verordening (EG) nr. 1272/2008 van het Europees Parlement en de Raad betreffende de indeling, etikettering en verpakking van stoffen en mengsels, met het oog op de aanpassing aan de technische en wetenschappelijke vooruitgang (PB L 116 van 5.5.2017)

C/2017/8747

PB L 342 van 21.12.2017, p. 85–96 (BG, HU, NL, SK)
PB L 342 van 21.12.2017, p. 85–85 (DA)

ELI: http://data.europa.eu/eli/reg/2017/776/corrigendum/2017-12-21/oj

HTML

PDF

Official Journal

The document is unavailable in your User interface language.

21.12.2017

Publicatieblad van de Europese Unie

L 342/85

( Publicatieblad van de Europese Unie L 116 van 5 mei 2017 )

Bladzijde 8, punt 3, onder d), ii), van de bijlage tot wijziging van tabel 3 in deel 3 van bijlage VI bij Verordening (EG) nr. 1272/2008 moet als volgt worden gelezen:

ii)

de vermeldingen voor de catalogusnummers 006-046-00-8, 604-057-00-8, 605-023-00-5, 606-041-00-6, 607-123-00-4, 608-055-00-8, 612-150-00-X, 613-318-00-5, 614-001-00-4, 615-013-00-2, 616-006-00-7, 616-094-00-7 en 650-032-00-X worden vervangen door:

Catalogusnummer	Internationale chemische identificatie	EG-nr.	CAS-nr.	Indeling		Etikettering			Specifieke concentratiegrenzen, M-factoren en ATE's	Opmerkingen
Catalogusnummer	Internationale chemische identificatie	EG-nr.	CAS-nr.	Gevarenklasse en categorie	Gevarenaanduiding	Pictogram, signaalwoord	Gevarenaanduiding	Aanvullende gevarenaanduiding	Specifieke concentratiegrenzen, M-factoren en ATE's	Opmerkingen
„006-046-00-8	bendiocarb (ISO); 2,2-dimethyl-1,3-benzodioxol-4-yl-N-methylcarbamaat; 2,2-dimethyl-1,3-benzodioxol-4-yl-methylcarbamaat	245-216-8	22781-23-3	Acute Tox. 3 Acute Tox. 3 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1	H331 H311 H300 H400 H410	GHS06 GHS09 Dgr	H331 H311 H300 H410		M = 10 M = 100”
„604-057-00-8	reactiemassa van: isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-(n)-dodecylfenol; isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-(n)-tetracosylfenol; isomeren van 2-(2H-benzotriazool-2-yl)-4-methyl-5,6-didodecyl-fenol. n = 5 of 6	401-680-5	—	Aquatic Chronic 4	H413		H413”
„605-023-00-5	5-chloor-2-(4-chloorfenoxy)fenol; [DCPP]	429-290-0	3380-30-1	Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1	H318 H400 H410	GHS05 GHS09 Dgr	H318 H410		M = 10 M = 10”
„606-041-00-6	2-methyl-1-(4-methylthiofenyl)-2-morfolinopropaan-1-on	400-600-6	71868-10-5	Repr. 1B Acute Tox. 4 * Aquatic Chronic 2	H360FD H302 H411	GHS08 GHS07 GHS09 Dgr	H360FD H302 H411”
„607-123-00-4	2,3-epoxypropylmethacrylaat; glycidylmethacrylaat	203-441-9	106-91-2	Carc. 1B Muta. 2 Repr. 1B Acute Tox. 3 Acute Tox. 4 STOT SE 3 STOT RE 1 Eye Dam. 1 Skin Corr. 1C Skin Sens. 1	H350 H341 H360F H311 H302 H335 H372 (luchtwegen) (inademing) H318 H314 H317	GHS08 GHS06 GHS05 Dgr	H350 H341 H360F H311 H302 H335 H372 (luchtwegen) (inademing) H314 H317			D”
„608-055-00-8	fipronil (ISO); (±)-5-amino-1-(2,6-dichloor-α,α,α-trifluor-para-tolyl)-4-trifluormethylsulfinyl-pyrazool-3-carbonitril	424-610-5	120068-37-3	Acute Tox. 3 * Acute Tox. 3 * Acute Tox. 3 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1	H301 H311 H331 H372 * H400 H410	GHS06 GHS08 GHS09 Dgr	H301 H311 H331 H372 * H410		M = 1 000 M = 10 000 ”
„612-150-00-X	spiroxamine (ISO); 8-tert-butyl-1,4-dioxaspiro[4.5]decaan-2-ylmethyl(ethyl)(propyl)amine	—	118134-30-8	Repr. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Irrit. 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H361d H332 H312 H302 H373 (oog) H315 H317 H400 H410	GHS08 GHS07 GHS09 Wng	H361d H332 H312 H302 H373 (oog) H315 H317 H410		M = 100 M = 100”
„613-318-00-5	fenpyrazamine (ISO); S-allyl-5-amino-2,3-dihydro-2-isopropyl-3-oxo-4-(o-tolyl)pyrazool-1-carbothioaat; S-allyl-5-amino-2-isopropyl-4-(2-methylfenyl)-3-oxo-2,3-dihydropyrazool-1-carbothioaat	—	473798-59-3	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Wng	H410		M = 10 M = 1”
„614-001-00-4	nicotine (ISO); 3-[(2S)-1-methylpyrrolidine-2-yl]pyridine	200-193-3	54-11-5	Acute Tox. 2 Acute Tox. 2 Acute Tox. 2 Aquatic Chronic 2	H330 H310 H300 H411	GHS06 GHS09 Dgr	H330 H310 H300 H411		inademing: ATE = 0,19 mg/L (stofdeeltjes of nevels) dermaal: ATE = 70 mg/kg oraal: ATE (*1) = 5 mg/kg”
„615-013-00-2	cyaanamide; carbanonitril	206-992-3	420-04-2	Carc. 2 Repr. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 2 Skin Corr. 1 Skin Sens. 1 Eye Dam. 1 Aquatic Chronic 3	H351 H361fd H311 H301 H373 (schildklier) H314 H317 H318 H412	GHS08 GHS06 GHS05 Dgr	H351 H361fd H311 H301 H373 (schildklier) H314 H317 H412”
„616-006-00-7	dichlofluanide (ISO); N-[(dichloorfluormethyl)thio]-N′,N′-dimethyl-N-fenylsulfamide	214-118-7	1085-98-9	Acute Tox. 4 Eye Irrit. 2 Skin Sens. 1 Aquatic Acute 1	H332 H319 H317 H400	GHS07 GHS09 Wng	H332 H319 H317 H400		M = 10”
„616-094-00-7	3,3′-dicyclohexyl-1,1′-methyleenbis(4,1-fenyleen)diureum	406-370-3	58890-25-8	Aquatic Chronic 4	H413		H413”
„650-032-00-X	cyproconazool (ISO); (2RS,3RS;2RS,3SR)-2-(4-chloorfenyl)-3-cyclopropyl-1-(1H-1,2,4-triazool-1-yl)butaan-2-ol	—	94361-06-5	Repr. 1B Acute Tox. 3 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1	H360D H301 H373 (lever) H400 H410	GHS08 GHS06 GHS09 Dgr	H360D H301 H373 (lever) H410		M = 10 M = 1”

Bladzijde 12, punt 3, onder d), iii), van de bijlage tot wijziging van tabel 3 in deel 3 van bijlage VI bij Verordening (EG) nr. 1272/2008 moet als volgt worden gelezen:

iii)

de volgende vermeldingen worden ingevoegd overeenkomstig de volgorde van de in tabel 3 opgenomen vermeldingen:

Catalogusnummer	Internationale chemische identificatie	EG-nr.	CAS-nr.	Indeling		Etikettering			Specifieke concentratiegrenzen, M-factoren en ATE's	Opmerkingen
Catalogusnummer	Internationale chemische identificatie	EG-nr.	CAS-nr.	Gevarenklasse en categorie	Gevarenaanduiding	Pictogram, signaalwoord	Gevarenaanduiding	Aanvullende gevarenaanduiding	Specifieke concentratiegrenzen, M-factoren en ATE's	Opmerkingen
„047-003-00-3	zilverzinkzeoliet (zeoliet, type LTA, oppervlakte gewijzigd met zilver- en zinkionen) [Deze rubriek betreft zeoliet van het type LTA (Linde-type A) waarvan de oppervlakte is gewijzigd met zowel zilver- als zinkionen met de gehalten Ag+ 0,5 % — 6 %, Zn2 + 5 % — 16 %, en eventueel met fosfor, NH4+, mg2+ en/of Ca2+, telkens < 3 %]	—	130328-20-0	Repr. 2 Skin Irrit. 2 Eye Dam. 1 Aquatic Acute 1 Aquatic Chronic 1	H361d H315 H318 H400 H410	GHS08 GHS05 GHS09 Dgr	H361d H315 H318 H410		M = 100 M = 100”
„048-012-00-5	cadmiumcarbonaat	208-168-9	513-78-0	Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1	H350 H340 H332 H312 H302 H372 (nier, bot) H400 H410	GHS08 GHS07 GHS09 Dgr	H350 H340 H332 H312 H302 H372 (nier, bot) H410			A1”
„048-013-00-0	cadmiumhydroxide; cadmiumdihydroxide	244-168-5	21041-95-2	Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1	H350 H340 H332 H312 H302 H372 (nier, bot) H400 H410	GHS08 GHS07 GHS09 Dgr	H350 H340 H332 H312 H302 H372 (nier, bot) H410			A1”
„048-014-00-6	cadmiumnitraat; cadmiumdinitraat	233-710-6	10325-94-7	Carc. 1B Muta. 1B Acute Tox. 4 * Acute Tox. 4 * Acute Tox. 4 * STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1	H350 H340 H332 H312 H302 H372 (nier, bot) H400 H410	GHS08 GHS07 GHS09 Dgr	H350 H340 H332 H312 H302 H372 (nier, bot) H410		Carc. 1B; H350: C ≥ 0,01 %	A1”
„050-030-00-3	dibutyltindilauraat; dibutyl[bis(dodecanoyloxy)]stannaan	201-039-8	77-58-7	Muta. 2 Repr. 1B STOT RE 1	H341 H360FD H372 (immuunsysteem)	GHS08 Dgr	H341 H360FD H372 (immuunsysteem)”
„603-235-00-2	linalool; 3,7-dimethyl-1,6-octadieen-3-ol; dl-linalool; [1] coriandrol; (S)-3,7-dimethyl-1,6-octadieen-3-ol; d-linalool; [2] licareol; (R)-3,7-dimethyl-1,6-octadieen-3-ol; l-linalool [3]	201-134-4 [1] 204-810-7 [2] 204-811-2 [3]	78-70-6 [1] 126-90-9 [2] 126-91-0 [3]	Skin Sens. 1B	H317	GHS07 Wng	H317”
„604-093-00-4	chlorofeen; 2-benzyl-4-chloorfenol	204-385-8	120-32-1	Carc. 2 Repr. 2 Acute Tox. 4 Skin Irrit. 2 Skin Sens. 1 Eye Dam. 1 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1	H351 H361f H332 H315 H317 H318 H373 (nier) H400 H410	GHS08 GHS05 GHS07 GHS09 Dgr	H351 H361f H332 H315 H317 H318 H373 (nier) H410		M = 1 M = 100”
„606-150-00-9	clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloorallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-on	—	99129-21-2	Acute Tox. 4 Skin Sens. 1 Aquatic Chronic 3	H302 H317 H412	GHS07 Wng	H302 H317 H412	EUH066”
„606-151-00-4	antrachinon	201-549-0	84-65-1	Carc. 1B	H350	GHS08 Dgr	H350”
„607-720-00-X	nonadecafluordecaanzuur; [1] ammoniumnonadecafluordecanoaat; [2] natriumnonadecafluordecanoaat [3]	206-400-3 [1] 221-470-5 [2] [3]	335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3]	Carc. 2 Repr. 1B Lact.	H351 H360Df H362	GHS08 Dgr	H351 H360Df H362”
„607-721-00-5	N,N′-methyleendimorfoline; N,N′-methyleenbismorfoline; [uit N,N′-methyleenbismorfoline vrijkomende formaldehyde]; [MBM]	227-062-3	5625-90-1	Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Skin Sens. 1 Eye Dam. 1	H350 H341 H332 H312 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H317 H318	GHS08 GHS07 GHS05 Dgr	H350 H341 H332 H312 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H317	EUH071		8 9”
„607-722-00-0	2,3,5,6-tetrafluor-4-(methoxymethyl)benzyl-(Z)-(1R,3R)-3-(2-cyaanprop-1-enyl)-2,2-dimethylcyclopropaan-carboxylaat; epsilon-momfluorothrine	—	1065124-65-3	Acute Tox. 4 STOT SE 2 Aquatic Acute 1 Aquatic Chronic 1	H302 H371 (zenuwstelsel) H400 H410	GHS07 GHS08 GHS09 Wng	H302 H371 (zenuwstelsel) H410		M = 100 M = 100”
„607-723-00-6	tefluthrin (ISO); 2,3,5,6-tetrafluor-4-methylbenzyl-(1RS,3RS)-3-[(Z)-2-chloor-3,3,3-trifluorprop-1-enyl]-2,2-dimethylcyclopropaan-carboxylaat	—	79538-32-2	Acute Tox. 1 Acute Tox. 2 Acute Tox. 2 Aquatic Acute 1 Aquatic Chronic 1	H330 H310 H300 H400 H410	GHS06 GHS09 Dgr	H330 H310 H300 H410		M = 10 000 M = 10 000 ”
„612-290-00-1	reactieproducten van paraformaldehyde en 2-hydroxypropylamine (verhouding 3:2); [uit 3,3′-methyleenbis[5-methyloxazolidine] vrijkomende formaldehyde; uit oxazolidine vrijkomende formaldehyde]; [MBO]	—	—	Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 3 Acute Tox. 4 STOT RE 2 Skin Corr. 1B Eye Dam. 1 Skin Sens. 1A Aquatic Chronic 2	H350 H341 H332 H311 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H318 H317 H411	GHS08 GHS06 GHS05 GHS09 Dgr	H350 H341 H332 H311 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H317 H411	EUH071		8 9”
„612-291-00-7	reactieproducten van paraformaldehyde met 2-hydroxypropylamine (verhouding 1:1); [uit α,α,α-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol vrijkomende formaldehyde]; [HPT]	—	—	Carc. 1B Muta. 2 Acute Tox. 4 Acute Tox. 4 STOT RE 2 Skin Corr. 1C Eye Dam. 1 Skin Sens. 1A Aquatic Chronic 2	H350 H341 H332 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H318 H317 H411	GHS08 GHS07 GHS05 GHS09 Dgr	H350 H341 H332 H302 H373 (spijsverteringskanaal, luchtwegen) H314 H317 H411	EUH071		8 9”
„612-292-00-2	methylhydrazine	200-471-4	60-34-4	Carc. 1B	H350	GHS08 Dgr	H350”
„613-321-00-1	(RS)-4-[1-(2,3-dimethylfenyl)ethyl]-1H-imidazool; medetomidine	—	86347-14-0	Acute Tox. 2 Acute Tox. 2 STOT SE 3 STOT SE 1 STOT RE 1 Aquatic Acute 1 Aquatic Chronic 1	H330 H300 H336 H370 (oog) H372 H400 H410	GHS06 GHS08 GHS09 Dgr	H330 H300 H336 H370 (oog) H372 H410		M = 1 M = 100”
„613-322-00-7	triadimenol (ISO); (1RS,2RS;1RS,2SR)-1-(4-chloorfenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazool-1-yl)butaan-2-ol; α-tert-butyl-β-(4-chloorfenoxy)-1H-1,2,4-triazool-1-ethanol	259-537-6	55219-65-3	Repr. 1B Lact. Acute Tox. 4 Aquatic Chronic 2	H360 H362 H302 H411	GHS08 GHS07 GHS09 Dgr	H360 H362 H302 H411”
„613-323-00-2	terbutylazine (ISO); N-tert-butyl-6-chloor-N′-ethyl-1,3,5-triazine-2,4-diamine	227-637-9	5915-41-3	Acute Tox. 4 STOT RE 2 Aquatic Acute 1 Aquatic Chronic 1	H302 H373 H400 H410	GHS07 GHS08 GHS09 Wng	H302 H373 H410		M = 10 M = 10”
„613-324-00-8	chinoline-8-ol; 8-hydroxychinoline	205-711-1	148-24-3	Repr. 1B Acute Tox. 3 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H360D H301 H318 H317 H400 H410	GHS08 GHS06 GHS05 GHS09 Dgr	H360D H301 H318 H317 H410		M = 1 M = 1”
„613-325-00-3	thiacloprid (ISO); (Z)-3-(6-chloor-3-pyridylmethyl)-1,3-thiazolidine-2-ylideencyaanamide; {(2Z)-3-[(6-chloorpyridine-3-yl)methyl]-1,3-thiazolidine-2-ylideen}cyaanamide	—	111988-49-9	Carc. 2 Repr. 1B Acute Tox. 4 Acute Tox. 3 STOT SE 3 Aquatic Acute 1 Aquatic Chronic 1	H351 H360FD H332 H301 H336 H400 H410	GHS08 GHS06 GHS09 Dgr	H351 H360FD H332 H301 H336 H410		M = 100 M = 100”
„616-221-00-6	hexaflumuron (ISO); 1-(3,5-dichloor-4-(1,1,2,2-tetrafluorethoxy)fenyl)-3-(2,6-difluorbenzoyl)ureum	401-400-1	86479-06-3	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Wng	H410		M = 1 000 M = 10 000 ”
„616-222-00-1	penthiopyrad (ISO); (RS)-N-[2-(1,3-dimethylbutyl)-3-thienyl]-1-methyl-3-(trifluormethyl)pyrazool-4-carboxamide	—	183675-82-3	Aquatic Acute 1 Aquatic Chronic 1	H400 H410	GHS09 Wng	H410		M = 1 M = 1”
„616-223-00-7	carbetamide (ISO); (R)-1-(ethylcarbamoyl)ethyl-carbanilaat; (2R)-1-(ethylamino)-1-oxopropaan-2-yl-fenylcarbamaat	240-286-6	16118-49-3	Carc. 2 Repr. 1B Acute Tox. 4 Aquatic Chronic 2	H351 H360D H302 H411	GHS08 GHS07 GHS09 Dgr	H351 H360D H302 H411”

(*1) Omgerekende puntschattingen van de acute toxiciteit overeenkomstig tabel 3.1.2 van bijlage I.

Top

Choose the experimental features you want to try